The University of Texas MD Anderson Cancer Center is a major cancer research hospital and part of the public University of Texas system. Its lobbying focuses on Medicare and Medicaid payment rules and cancer-related Medicare reimbursements, federal budget and appropriations that fund health programs, and rules affecting health agencies like NIH, CDC, CMS, and FDA. It reported about $1.3 million across four filings, most recently in January 2026.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
EDWARD MILLER
The latest disclosures for this client.
THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
1ATHE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
1AThe entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
Q1THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
Q4THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
Q3THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
Q2THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
Q1